​

Funding Round

Post-IPO Debt - Acumen Pharmaceuticals

Post-IPO Debt - Acumen Pharmaceuticals

Investment Firm

Overview

Acumen is developing targeted therapies for the safe and effective treatment of Alzheimer’s Disease and related neurodegenerative diseases.

Announced Date

Nov 13, 2023

Funding Type

Post Ipo Debt

Highlights

Location

United States, North America

Social

Investor Lead

K2 HealthVentures

K2 HealthVentures

K2 HealthVentures is a debt and early_stage_venture and late_stage_venture and post_ipo and private_equity firm.

Participant Investors

1

Investor Name
Participant InvestorK2 HealthVentures

Round Details and Background

Acumen Pharmaceuticals raised $50000000 on 2023-11-13 in Post-IPO Debt

Acumen is developing targeted therapies for the safe and effective treatment of Alzheimer’s Disease and related neurodegenerative diseases.

Company Funding History

7

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 17, 2023
Post-IPO Equity - Acumen Pharmaceuticals
-130.0M
Nov 13, 2023
Post-IPO Debt - Acumen Pharmaceuticals
1-50.0M
May 15, 2013
Series A - Acumen Pharmaceuticals
-20.0M
Aug 17, 2006
Venture Round - Acumen Pharmaceuticals
1-1.5M

Recent Activity

There is no recent news or activity for this profile.